Young W. Nam
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: EGFR inhibits TNF-α-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401.
Journal: Cell death and differentiation
Published: December 03, 2024
Opposing regulation of the K63-linked polyubiquitination of RIPK3 by SMURF1 and USP5 in necroptosis.
Opposing regulation of the K63-linked polyubiquitination of RIPK3 by SMURF1 and USP5 in necroptosis.
Journal: Nature communications
Published: October 18, 2024
Development of a targeted IL-12 immunotherapy platform for B-cell lymphomas.
Journal: International immunopharmacology
Published: January 30, 2024
EGFR inhibits TNF-α-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401.
Journal: Cell death and differentiation
Published: July 27, 2023
IKK-mediated TRAF6 and RIPK1 interaction stifles cell death complex assembly leading to the suppression of TNF-α-induced cell death.
Journal: Cell death and differentiation
Published: July 27, 2022
Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators.
Journal: Experimental & molecular medicine
Published: January 08, 2021
Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 06, 2020
Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex.
Journal: Cell death and differentiation
Published: September 02, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026